成人糖尿病患者体重变化后心血管疾病风险:队列研究与荟萃分析
该研究包含队列研究与荟萃分析,评估8920例2型糖尿病患者18个月体重变化与后续大血管及微血管并发症风险。与体重稳定者相比,体重增加≥5%、增加1%-5%、减少≥5%均与总血管并发症风险升高相关,体重减少≥5%还与微血管并发症风险升高相关,荟萃分析结果相似。
要点
- 18个月体重增加≥5%者总血管并发症风险升高(HR=1.43,95%CI 1.10-1.85)。
- 18个月体重减少≥5%者总血管并发症风险升高(HR=1.58,95%CI 1.20-2.08)。
- 体重变化≥5%可能是不良心血管结局的警示信号。
核心结论
- 2型糖尿病患者18个月内体重增加或减少,尤其是变化≥5%,可能是不良心血管结局的警示信号。
研究设计与样本
- 研究由一项队列研究和一项荟萃分析组成,队列研究纳入8920例有有效体重测量的2型糖尿病患者。
- 队列研究将18个月体重变化分为:增加≥5%、增加1%-5%、稳定(-1%-1%)、减少1%-5%、减少≥5%。
- 采用Cox回归分析估计风险比(HR)和95%置信区间(95%CI),并用随机效应模型合并本研究与其他相关研究结果。
主要发现
- 与体重稳定者相比,体重增加≥5%者总血管并发症风险升高(HR=1.43,95%CI 1.10-1.85)。
- 与体重稳定者相比,体重增加1%-5%者总血管并发症风险升高(HR=1.44,95%CI 1.02-2.03)。
- 与体重稳定者相比,体重减少≥5%者总血管并发症风险升高(HR=1.58,95%CI 1.20-2.08)。
- 与体重稳定者相比,体重增加≥5%者大血管并发症风险升高(HR=1.84,95%CI 1.16-2.91);体重减少1%-5%者大血管并发症风险升高(HR=1.91,95%CI 1.06-3.43);体重减少≥5%者大血管并发症风险升高(HR=2.18,95%CI 1.36-3.49)。
- 与体重稳定者相比,体重减少≥5%者微血管并发症风险升高(HR=1.48,95%CI 1.06-2.06);荟萃分析显示相似结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Weight management is recognized as critical in reducing cardio-metabolic risk factors for adults with diabetes, but the effects of weight change on cardiovascular disease in patients with diabetes are unknown. OBJECTIVE: To evaluate 18-month weight change and subsequent risk of macrovascular and microvascular complications in established individuals with type 2 diabetes. DESIGN AND SETTING: This study consisted of a cohort study and a meta-analysis. In the cohort study, weight change over 18 months was divided into: gain ≥5%, gain 1%-5%, stable (-1%-1%), loss 1%-5%, and loss ≥5%. Cox regression analyses were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI). We then used random-effect models to pool the results combing our study with other relevant studies. RESULTS: In the cohort study, 8920 participants with valid weight measurements were included. Compared with patients with stable weight, higher risks were seen in those with weight change for total vascular complications (gain ≥5%: HR=1.43, 95% CI: 1.10-1.85; gain 1-5%: HR=1.44, 95% CI: 1.02-2.03; loss ≥5%: HR=1.58, 95% CI: 1.20-2.08), macrovascular complications (gain ≥5%: HR=1.84, 95% CI: 1.16-2.91; loss 1-5%: HR=1.91, 95% CI: 1.06-3.43; loss ≥5%: HR=2.18, 95% CI: 1.36-3.49) and microvascular complications (loss ≥5%: HR=1.48, 95% CI: 1.06-2.06). Meta-analysis also showed similar results. CONCLUSIONS: Weight gain and loss over 18 months among patients with type 2 diabetes, especially weight change ≥5%, may be a warning sign of adverse cardiovascular outcomes.
引用
- Dong Y, Chen Z, Gong Y, et al. The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089). J Clin Endocrinol Metab. 2022. PMID: 35971852. doi:10.1210/clinem/dgac485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。